Every Form 4 that Definitive Healthcare Corp. (DH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow DH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DH filings page.
Definitive Healthcare Corp. (DH) reported that Chief Financial Officer Casey Heller had 41,093 shares of Class A common stock withheld by the issuer on September 1, 2026 to satisfy tax withholding obligations related to the vesting and settlement of previously reported RSUs, at a reference price of $0.9023 per share. Following this tax-withholding disposition, Heller directly holds 1,798,502 shares of Class A common stock, and no Rule 10b5-1 trading plan is reported.
Definitive Healthcare Corp. Executive Chairman and 10% owner Jason Ronald Krantz had 12,166 shares of Class A common stock withheld by the issuer on August 1, 2026 to satisfy tax obligations arising from the vesting and settlement of previously reported RSUs at $0.6823 per share.
Following this tax-withholding disposition, he directly holds 1,189,272 shares of Class A common stock and indirectly beneficially owns 450,000 shares through DH Holdings (formerly Jason R. Krantz 2009 Trust), of which he is the beneficiary.
Definitive Healthcare Corp. reported that Chief Financial Officer Casey Heller had 1,881 shares of Class A Common Stock withheld on August 1, 2026 to satisfy tax withholding obligations upon vesting of previously reported RSUs. After this tax-withholding disposition, Heller directly holds 1,839,595 shares.
Definitive Healthcare Corp. CEO Kevin Coop reported a tax-related share disposition tied to vested restricted stock units. On this Form 4, the issuer withheld 37,593 shares of Class A common stock at $0.80 per share to cover Coop’s tax withholding obligations upon RSU settlement. This was not an open-market sale, and after the withholding, Coop directly owns 4,975,229 shares of Class A common stock.
Definitive Healthcare Corp. reported that Chief Legal Officer Jonathan Paris had shares withheld to cover taxes tied to equity compensation. The issuer withheld 30,591 shares of Class A Common Stock at $0.80 per share to satisfy his tax withholding obligations upon vesting and settlement of previously reported RSUs. After this non-market tax-withholding disposition, Paris directly holds 872,263 shares of Class A Common Stock.
Hamood Samuel A reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp. director Samuel A. Hamood received a grant of 189,190 restricted stock units, each representing one share of Class A Common Stock at no cash cost. These RSUs vest on the earlier of June 4, 2027 or the company’s next annual stockholder meeting, subject to his continued service.
Following this award, Hamood directly holds 289,396 Class A shares and has an additional 51,582 shares reported as indirectly held through AMHAM DH LLC.
Stephenson Scott G reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp. reported that director Scott G. Stephenson received a grant of 189,190 shares of Class A Common Stock in the form of restricted stock units. Each RSU represents a contingent right to one share and will vest on the earlier of June 4, 2027 or the company’s next annual stockholder meeting, subject to his continued service. Following this award, Stephenson directly holds 313,314 shares of Class A Common Stock.
Winters Kathleen A reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp. reported that director Kathleen A. Winters received a grant of 189,190 restricted stock units (RSUs) of Class A Common Stock. The award carries no purchase price and increases her direct holdings to 308,982 shares. These RSUs vest on the earlier of June 4, 2027 or the company’s next annual meeting of stockholders, assuming she continues in service until that vesting date. This is a compensation-related equity grant rather than an open-market transaction.
Chilukuri Sastry reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp. director Chilukuri Sastry received an equity grant of 189,190 shares of Class A Common Stock in the form of restricted stock units. These RSUs carry no purchase price and increase his direct holdings to 315,984 shares after the award.
Each RSU represents a contingent right to receive one share of Class A Common Stock. The units vest on the earlier of June 4, 2027 or the date of the company’s next annual stockholder meeting, conditioned on his continued service through the vesting date.
Definitive Healthcare Corp.'s Chief Financial Officer Casey Heller reported a routine share disposition tied to taxes rather than a market trade. The company withheld 164,377 shares of Class A common stock at an effective value of $0.99 per share to cover Heller's tax obligations from vesting restricted stock units. After this tax-withholding transaction, Heller directly holds 1,841,476 shares of Class A common stock, indicating a substantial remaining equity position in the company.
Definitive Healthcare Corp. reported that CEO Kevin Coop had shares withheld to cover taxes tied to restricted stock units vesting. The Form 4 shows a tax-withholding disposition of 66,050 shares of Class A Common Stock at $0.99 per share, with no open-market trade. After this transaction, Coop is reported as directly owning 5,012,822 Class A shares, so the withheld amount is a small portion of his overall holdings and reflects a compensation-related event rather than a discretionary stock sale.
Definitive Healthcare Corp. executive chairman and major shareholder Jason Ronald Krantz reported a share disposition that was purely for tax purposes. On the vesting and settlement of previously reported RSUs, 12,166 shares of Class A common stock were withheld by the company at $0.99 per share to satisfy his tax withholding obligations, rather than being sold in the open market. After this transaction, Krantz directly holds 1,201,438 Class A shares and indirectly benefits from 450,000 shares held in a trust named DH Holdings (formerly the Jason R. Krantz 2009 Trust).
Definitive Healthcare Corp. Chief Financial Officer Casey Heller reported a small share disposition related to tax withholding. On May 1, 2026, 1,469 shares of Class A Common Stock were withheld at $0.99 per share to satisfy tax obligations upon vesting of previously reported RSUs. After this non‑market transaction, Heller directly holds 2,005,853 shares of Class A Common Stock.
Definitive Healthcare Corp. CEO Kevin Coop had 37,593 shares of Class A Common Stock withheld on April 1 to cover tax obligations tied to vesting RSUs. This was a tax-withholding disposition, not an open-market sale. After this event, he directly holds 5,078,872 shares.
Definitive Healthcare Corp. director and executive chairman Jason Ronald Krantz had 45,154 shares of Class A Common Stock withheld on April 1, 2026 at $1.09 per share to cover tax obligations tied to the vesting of previously reported RSUs. This was a tax-withholding disposition, not an open-market sale, and was satisfied by the issuer delivering shares for the liability.
After this event, Krantz directly held 1,213,604 shares of Class A Common Stock. He also beneficially owned an additional 450,000 shares held in trust by DH Holdings (f/k/a Jason R. Krantz 2009 Trust), of which he is the beneficiary.
Definitive Healthcare Corp. reported that Chief Executive Officer Kevin Coop had 175,524 shares of Class A common stock withheld by the company at $1.28 per share. These shares were retained by the issuer to cover Coop's tax withholding obligations tied to the vesting and settlement of previously reported restricted stock units, rather than being sold in an open-market transaction. After this tax-withholding disposition, Coop directly holds 5,116,465 shares of Definitive Healthcare common stock.
Graboske Benjamin reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp. reported that EVP and Chief Data Officer Benjamin Graboske received a grant of 631,068 restricted stock units (RSUs) of Class A Common Stock. The award was recorded at a price of $0.00 per share, reflecting stock-based compensation rather than a cash purchase.
Each RSU represents a contingent right to receive one share of Class A Common Stock. According to the disclosure, 25% of these RSUs are scheduled to vest on March 1, 2027, with additional vesting at a rate of 6.25% thereafter. Following this grant, Graboske’s directly owned Class A Common Stock, including RSUs, totaled 1,312,026.654 shares.
Paris Jonathan reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp. reported that Chief Legal Officer Jonathan Paris received a grant of 481,505 restricted stock units, each representing one share of Class A common stock. According to the award terms, 25% of these RSUs vest on March 1, 2027, with 6.25% vesting every three months over the following three years, contingent on his continued service.
Heller Casey reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp.’s Chief Financial Officer, Casey Heller, reported an equity award of 733,301 restricted stock units (RSUs) tied to the company’s Class A common stock at a stated price of $0.00 per share. Each RSU represents a contingent right to receive one share.
According to the filing, 25% of these RSUs will vest on March 1, 2027, with an additional 6.25% vesting every three months over the following three years, as long as Heller remains in service. After this grant, Heller directly holds 2,007,322 shares or RSUs linked to Class A common stock.
Coop Kevin reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp. reported that Chief Executive Officer Kevin Coop received an equity award linked to 1,735,437 shares of Class A Common Stock in the form of restricted stock units. These RSUs vest 25% on March 1, 2027, then 6.25% every three months over the next three years, contingent on his continued service. Following this grant, Coop is reported as beneficially owning 5,291,989 shares of Class A Common Stock.
Definitive Healthcare Corp. executive chairman and 10% owner Jason Ronald Krantz reported an equity award. On February 24, 2026, he acquired 242,719 restricted stock units, each representing one share of Class A common stock, at no cost. These RSUs vest 100% on March 1, 2027, subject to his continued service. After this grant, he directly holds 1,258,758 shares. He also has indirect beneficial ownership of 450,000 shares through DH Holdings, formerly the Jason R. Krantz 2009 Trust, where he is the beneficiary.
Definitive Healthcare Corp. Executive Chairman Jason Ronald Krantz reported a tax-related share withholding on February 1, 2026. The issuer withheld 44,545 shares of Class A Common Stock at $2.32 per share to cover tax obligations linked to vesting of previously reported restricted stock units.
After this transaction, Krantz beneficially owned 1,016,039 Class A shares directly and 450,000 shares indirectly through DH Holdings (formerly the Jason R. Krantz 2009 Trust), where he is the beneficiary.
Definitive Healthcare Corp. reported a routine insider tax withholding transaction by its Chief Financial Officer. On 02/01/2026, CFO Casey Heller had 1,469 shares of Class A common stock withheld by the company at $2.32 per share to cover tax obligations tied to vesting restricted stock units. After this withholding, Heller beneficially owned 1,274,021 Class A common shares directly.
Definitive Healthcare Corp. reported that its Chief Financial Officer, Casey Heller, received an equity grant of 195,313 Class A common shares in the form of restricted stock units on January 5, 2026. These RSUs carry a grant price of $0 per share, reflecting a compensation award rather than an open-market purchase.
Each RSU represents the right to receive one share of Class A common stock, with 50% vesting on January 1, 2027. The remaining half vests in equal quarterly installments over the following 12 months, conditioned on Heller’s continued service with the company. After this grant, Heller directly beneficially owns 1,275,490 shares of Class A common stock.
Definitive Healthcare Corp. (DH) disclosed an insider transaction by its Chief Financial Officer on a Form 4. On 11/01/2025, the CFO had 1,244 shares of Class A common stock withheld at $2.77 per share under transaction code F, which indicates shares were withheld to cover taxes on vested restricted stock units. Following this administrative withholding, the officer beneficially owns 1,080,177 shares directly. The footnote confirms the activity was tied to the vesting and settlement of previously reported RSUs.
Definitive Healthcare (DH) reported an insider transaction by its Executive Chairman and Director. On 11/01/2025, 18,796 shares of Class A common stock were withheld by the company at $2.77 per share to cover tax obligations upon the vesting and settlement of previously reported RSUs. Following this administrative transaction, the reporting person beneficially owns 1,060,584 shares directly and 450,000 shares indirectly through DH Holdings (f/k/a Jason R. Krantz 2009 Trust), of which he is the beneficiary.
Definitive Healthcare Corp. reporting person Casey Heller, the company's Chief Financial Officer, disclosed a transaction on 10/01/2025 in which 8,300 shares of Class A common stock were disposed of at $3.56 per share. After the reported sale, the filing shows the reporting person beneficially owns 1,081,421 shares. The form explains the transaction reflects shares withheld by the issuer to satisfy the reporting person’s tax withholding obligations related to the vesting and settlement of previously reported restricted stock units. The filing is an individual Form 4 and was signed by an attorney-in-fact on behalf of the reporting person.
Kevin Coop, who is listed as both Chief Executive Officer and a Director of Definitive Healthcare Corp. (DH), reported a transaction on 10/01/2025. The report shows a Code F(1) transaction disposing of 37,593 shares of Class A common stock at a price of $3.56 per share. The filing explains these shares were withheld by the issuer to satisfy the reporting person’s tax withholding obligations related to the vesting and settlement of previously reported restricted stock units. After the withholding, the reporting person beneficially owned 3,584,788 shares, held directly. The form is signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025.